These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5046010)

  • 1. [Peroral long-acting drugs. VII. Tablets prepared of a granulated powder coated with fatty acids].
    Chalabala M; Starha L; Muzik M
    Cesk Farm; 1972 May; 21(4):153-5. PubMed ID: 5046010
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peroral drugs with delayed action. V. Relation between the moulding pressure and the release of drugs].
    Starha L; Chalabala M
    Cesk Farm; 1971 Jan; 20(1):23-5. PubMed ID: 5546597
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
    Cerea M; Zheng W; Young CR; McGinity JW
    Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycerin ester of higher fatty acids as pharmaceutic aids. 6. Release of an imbedded drug from tablets containing higher fatty acids and their esters].
    Chalabala M; Starha L
    Pharmazie; 1970 Sep; 25(9):535-8. PubMed ID: 5486680
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery.
    Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmaceutical technology of Cordaflex tablets].
    Erdös S
    Acta Pharm Hung; 1996 Jan; 66(1):41-5. PubMed ID: 8714364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral long-acting drugs. II. Tablets with soluble drug mixed with hardened castor oil].
    Starha L; Chalabala M
    Cesk Farm; 1969 Mar; 18(2):80-2. PubMed ID: 5779797
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard].
    Chalabala M; Starha L
    Cesk Farm; 1970 Jun; 19(5):184-6. PubMed ID: 5448541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Obtaining of prolonged action of drugs based on insoluble matrix].
    Chodkowska-Granicka B; Michalski K; Surowiecki J; Pawlak E; Trojanowska Z
    Acta Pol Pharm; 1970; 27(3):285-90. PubMed ID: 5456904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of various factors on the velocity of drug release from depot tablets. 2. Isoniazid-depot tablets].
    Naplatanova D; Tomassini L
    Pharmazie; 1974 May; 29(5):321-3. PubMed ID: 4848951
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
    Möller T; Korsatko W
    Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technology of pharmaceutic powders: tablets produced using a special technology].
    Arecco D; Bassi M; Gabrielli B; Merlini A
    Boll Chim Farm; 1976 Oct; 115(10):680-701. PubMed ID: 1016598
    [No Abstract]   [Full Text] [Related]  

  • 20. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties.
    Herting MG; Kleinebudde P
    Int J Pharm; 2007 Jun; 338(1-2):110-8. PubMed ID: 17324537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.